Offc Action Outgoing

TANDEM MOBI

Tandem Diabetes Care, Inc.

U.S. Trademark Application Serial No. 90207218 - TANDEM MOBI - 77315.128

To: Tandem Diabetes Care, Inc. (IPdocket@thompsonhine.com)
Subject: U.S. Trademark Application Serial No. 90207218 - TANDEM MOBI - 77315.128
Sent: November 13, 2020 09:01:05 PM
Sent As: ecom105@uspto.gov
Attachments: Attachment - 1
Attachment - 2

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

U.S. Application Serial No. 90207218

 

Mark:  TANDEM MOBI

 

 

 

 

Correspondence Address: 

LOUIS K. EBLING

THOMPSON HINE LLP

312 WALNUT STREET, SUITE 1400

CINCINNATI, OH 45202

 

 

 

Applicant:  Tandem Diabetes Care, Inc.

 

 

 

Reference/Docket No. 77315.128

 

Correspondence Email Address: 

 IPdocket@thompsonhine.com

 

 

 

NONFINAL OFFICE ACTION

 

The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned.  Respond using the Trademark Electronic Application System (TEAS).  A link to the appropriate TEAS response form appears at the end of this Office action. 

 

 

Issue date:  November 13, 2020

 

 The referenced application has been reviewed by the assigned trademark examining attorney.  Applicant must respond timely and completely to the issue(s) below.  15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.

 

SUMMARY OF ISSUES:

  • ADVISORY: PRIOR-FILED PENDING APPLICATION
  • IDENTIFICATION AND CLASSIFICATION OF GOODS

 

SEARCH OF USPTO DATABASE OF MARKS

 

The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting registered marks that would bar registration under Trademark Act Section 2(d).  15 U.S.C. §1052(d); TMEP §704.02.  However, a mark in a prior-filed pending application may present a bar to registration of applicant’s mark.

 

ADVISORY: PRIOR-FILED PENDING APPLICATION

 

The filing date of pending U.S. Application Serial No. 88344970 precedes applicant’s filing date.  See attached referenced application.  If the mark in the referenced application registers, applicant’s mark may be refused registration under Trademark Act Section 2(d) because of a likelihood of confusion between the two marks.  See 15 U.S.C. §1052(d); 37 C.F.R. §2.83; TMEP §§1208 et seq.  Therefore, upon receipt of applicant’s response to this Office action, action on this application may be suspended pending final disposition of the earlier-filed referenced application.

 

In response to this Office action, applicant may present arguments in support of registration by addressing the issue of the potential conflict between applicant’s mark and the mark in the referenced application.  Applicant’s election not to submit arguments at this time in no way limits applicant’s right to address this issue later if a refusal under Section 2(d) issues.

 

IDENTIFICATION AND CLASSIFICATION OF GOODS

 

The identification of goods is indefinite and must be clarified.  See 37 C.F.R. §2.32(a)(6); TMEP §1402.01.  Applicant must amend the identification to specify the common commercial or generic name of the goods.  See TMEP §1402.01.  If the goods have no common commercial or generic name, applicant must describe the product, its main purpose, and its intended uses.  See id.

 

Specifically, applicant must amend the following wording in the identification of goods.

 

The wording “Medical devices, namely, drug delivery systems” in the identification of goods is indefinite and must be clarified because applicant must indicate the common commercial name of the goods.  See 37 C.F.R. §2.32(a)(6); TMEP §1402.01.

 

Applicant will also note that in the identification of goods, applicant must use the common commercial or generic names for the goods, be as complete and specific as possible, and avoid the use of indefinite words and phrases.  TMEP §1402.03(a); see 37 C.F.R. §2.32(a)(6).  If applicant uses indefinite words such as “apparatus,” “components,” “devices,” “materials,” or “parts,” such wording must be followed by “namely,” and a list of each specific product identified by its common commercial or generic name.  See TMEP §§1401.05(d), 1402.03(a).

 

Furthermore, applicant has classified “infusion and injection device controllers” in International Class 10; however, the proper classification is International Class 9.  Therefore, applicant may respond by reclassifying the goods in the proper international class or deleting this wording.  See 37 C.F.R. §§2.86(a), 6.1; TMEP §§1403.02 et seq.

 

Applicant may adopt the following identification, if accurate: 

 

International Class 9: Recorded and downloadable software and hardware for use in managing diabetes; recorded and downloadable software and hardware for linking medical instruments and devices; electronic controllers for infusion and injection devices

 

International Class 10: Medical devices, namely, drug delivery systems in the nature of {indicate the common commercial name of the goods, e.g., drug delivery patches sold without medication, implantable drug delivery ports, intravenous bags sold empty for intravenous therapy}; medical apparatus, namely, infusion and injection devices for administering drugs and other medicaments; infusion and injection device controllers; parts and fittings for the aforesaid goods, namely, {indicate the common commercial name of the goods, e.g., hypodermic needles}

 

Applicant’s goods and/or services may be clarified or limited, but may not be expanded beyond those originally itemized in the application or as acceptably amended.  See 37 C.F.R. §2.71(a); TMEP §1402.06.  Applicant may clarify or limit the identification by inserting qualifying language or deleting items to result in a more specific identification; however, applicant may not substitute different goods and/or services or add goods and/or services not found or encompassed by those in the original application or as acceptably amended.  See TMEP §1402.06(a)-(b).  The scope of the goods and/or services sets the outer limit for any changes to the identification and is generally determined by the ordinary meaning of the wording in the identification.  TMEP §§1402.06(b), 1402.07(a)-(b).  Any acceptable changes to the goods and/or services will further limit scope, and once goods and/or services are deleted, they are not permitted to be reinserted.  TMEP §1402.07(e).

 

For assistance with identifying and classifying goods and services in trademark applications, please see the USPTO’s online searchable U.S. Acceptable Identification of Goods and Services Manual.  See TMEP §1402.04.

 

Please call or email the assigned trademark examining attorney with questions about this Office action. 

 

 

How to respond.  Click to file a response to this nonfinal Office action.    

 

 

/Joanna E. H. Fiorelli/

Joanna E. H. Fiorelli

Trademark Examining Attorney

Law Office 105

571-272-4245

joanna.fiorelli@uspto.gov

 

 

RESPONSE GUIDANCE

  • Missing the response deadline to this letter will cause the application to abandon.  A response or notice of appeal must be received by the USPTO before midnight Eastern Time of the last day of the response period.  TEAS and ESTTA maintenance or unforeseen circumstances could affect an applicant’s ability to timely respond.  

 

 

 

Offc Action Outgoing [image/jpeg]

Offc Action Outgoing [image/jpeg]

U.S. Trademark Application Serial No. 90207218 - TANDEM MOBI - 77315.128

To: Tandem Diabetes Care, Inc. (IPdocket@thompsonhine.com)
Subject: U.S. Trademark Application Serial No. 90207218 - TANDEM MOBI - 77315.128
Sent: November 13, 2020 09:01:06 PM
Sent As: ecom105@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

 

USPTO OFFICIAL NOTICE

 

Office Action (Official Letter) has issued

on November 13, 2020 for

U.S. Trademark Application Serial No. 90207218

 

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter that you must respond to by the specified deadline or your application will be abandoned.  Please follow the steps below.

 

(1)  Read the official letter.

 

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

 

 

/Joanna E. H. Fiorelli/

Joanna E. H. Fiorelli

Trademark Examining Attorney

Law Office 105

571-272-4245

joanna.fiorelli@uspto.gov

 

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

 

(3)  Respond within 6 months (or earlier, if required in the Office action) from November 13, 2020, using the Trademark Electronic Application System (TEAS).  The response must be received by the USPTO before midnight Eastern Time of the last day of the response period.  See the Office action for more information about how to respond

 

 

 

GENERAL GUIDANCE

·         Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

 

·         Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

 

·         Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”

 

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed